|
1
|
Pieters R, Appel I, Kuehnel HJ,
Tetzlaff-Fohr I, Pichlmeier U, Van Der Vaart I, Visser E and
Stigter R: Pharmacokinetics, pharmacodynamics, efficacy, and safety
of a new recombinant asparaginase preparation in children with
previously untreated acute lymphoblastic leukemia: A randomized
phase 2 clinical trial. Blood. 112:4832–4838. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Appel IM, Den Boer ML, Meijerink JP,
Veerman AJ, Reniers NC and Pieters R: Up-regulation of asparagine
synthetase expression is not linked to the clinical response to
L-asparaginase in pediatric acute lymphoblastic leukemia. Blood.
107:4244–4249. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Den Boer ML, van Slegtenhorst M, De
Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST, Van Zutven LJ,
Beverloo HB, Van der Spek PJ, Escherich G, et al: A subtype of
childhood acute lymphoblastic leukaemia with poor treatment
outcome: A genome-wide classification study. Lancet Oncol.
10:125–134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Richards NG and Kilberg MS: Asparagine
synthetase chemotherapy. Annu Rev Biochem. 75:629–654. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Su N, Pan YX, Zhou M, Harvey RC, Hunger SP
and Kilberg MS: Correlation between asparaginase sensitivity and
asparagine synthetase protein content, but not mRNA, in acute
lymphoblastic leukemia cell lines. Pediatr Blood Cancer.
50:274–279. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Accordi B, Galla L, Milani G, Curtarello
M, Serafin V, Lissandron V, Viola G, te Kronnie G, De Maria R,
Petricoin EF III, et al: AMPK inhibition enhances apoptosis in
MLL-rearranged pediatric B-acute lymphoblastic leukemia cells.
Leukemia. 27:1019–1027. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dimitriou H, Choulaki C, Perdikogianni C,
Stiakaki E and Kalmanti M: Expression levels of ASNS in mesenchymal
stromal cells in childhood acute lymphoblastic leukemia. Int J
Hematol. 99:305–310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chien WW, Le Beux C, Rachinel N, Julien M,
Lacroix CE, Allas S, Sahakian P, Cornut-Thibaut A, Lionnard L,
Kucharczak J, et al: Differential mechanisms of asparaginase
resistance in B-type acute lymphoblastic leukemia and malignant
natural killer cell lines. Sci Rep. 5:80682015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patel N, Krishnan S, Offman MN, Krol M,
Moss CX, Leighton C, van Delft FW, Holland M, Liu J, Alexander S,
et al: A dyad of lymphoblastic lysosomal cysteine proteases
degrades the antileukemic drug L-asparaginase. J Clin Invest.
119:1964–1973. 2009.PubMed/NCBI
|
|
10
|
Hermanova I, Zaliova M, Trka J and
Starkova J: Low expression of asparagine synthetase in lymphoid
blasts precludes its role in sensitivity to L-asparaginase. Exp
Hematol. 40:657–665. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krejci O, Starkova J, Otava B, Madzo J,
Kalinova M, Hrusak O and Trka J: Upregulation of asparagine
synthetase fails to avert cell cycle arrest induced by
L-asparaginase in TEL/AML1-positive leukemic cells. Leukemia.
18:434–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He Y, Li B, Luo C, Shen S, Chen J, Xue H,
Tang J and Gu L: Asparagine synthetase is partially localized to
the plasma membrane and upregulated by L-asparaginase in U937
cells. J Huazhong Univ Sci Technol Med Sci. 31:159–163. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lomelino CL, Andring JT, McKenna R and
Kilberg MS: Asparagine synthetase: Function, structure, and role in
disease. J Biol Chem. 292:19952–19958. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Strefford JC, van Delft FW, Robinson HM,
Worley H, Yiannikouris O, Selzer R Richmond T, Hann I, Bellotti T,
Raghavan M, et al: Complex genomic alterations and gene expression
in acute lymphoblastic leukemia with intrachromosomal amplification
of chromosome 21. Proc Natl Acad Sci USA. 103:8167–8172. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stams WA, Den Boer ML, Beverloo HB,
Meijerink JP, Stigter RL, Van Wering ER, Janka-Schaub GE, Slater R
and Pieters R: Sensitivity to L-asparaginase is not associated with
expression levels of asparagine synthetase in t(12;21)+pediatric
ALL. Blood. 101:2743–2747. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aslanian AM, Fletcher BS and Kilberg MS:
L-asparaginase resistance in MOLT-4 human leukaemia cells. Biochem
J. 357:321–328. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
International BFM Study Group, : A
randomized trial of the I-BFM-SG for the management of childhood
ALL IC-BFM. 2009.
|
|
18
|
Stary J, Zimmermann M, Campbell M,
Castillo L, Dibar E, Donska S, Gonzalez A, Izraeli S, Janic D,
Jazbec J, et al: Intensive chemotherapy for childhood acute
lymphoblastic leukemia: Results of the randomized intercontinental
trial ALL IC-BFM 2002. J Clin Oncol. 32:174–184. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wingender E: TheTRANSFAC project as an
example of framework technology that supports the analysis of
genomic regulation. Brief Bioinform. 9:326–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wenzinger C, Williams E and Gru AA:
Updates in the pathology of precursor lymphoid neoplasms in the
revised fourth edition of the WHO classification of tumors of
hematopoietic and lymphoid tissues. Curr Hematol Malig Rep.
13:275–288. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Moorman AV: New and emerging prognostic
and predictive genetic biomarkers in B-cell precursor acute
lymphoblastic leukemia. Haematologica. 101:407–416. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schwab C, Nebral K, Chilton L, Leschi C,
Waanders E, Boer JM, Žaliová M, Sutton R, Öfverholm II, Ohki K, et
al: Intragenic amplification of PAX5: A novel subgroup in B-cell
precursor acute lymphoblastic leukemia? Blood Adv. 1:1473–1477.
2017. View Article : Google Scholar : PubMed/NCBI
|
